
News|Articles|September 15, 2019
Why Pharmacopoeia Compliance Is Difficult–An End-to-End Compendial Framework (PDF)
Author(s)J. Mark Wiggins, Joseph A. Albanese
This article provides an end-to-end compendial framework to understand why compliance with pharmacopoeia standards is challenging.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Drug Digest: How Advanced Analytics Partnerships Enhance the Biopharma Value Chain
3
PharmTech Weekly Roundup—June 26, 2026
4
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
5




